Tobacco Companies Are Cashing In on Zyn’s Unstoppable Popularity
Tobacco companies are leveraging the surge in nicotine pouch popularity as consumers shift away from traditional cigarettes and vapes.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Nicotine pouches, including Zyn, are experiencing a significant rise in popularity. In the UK, a Haypp report indicates these products are gaining ground as alternatives to vaping, with women emerging as a key driver of growth. A separate survey shows 95% of users are happy after moving from cigarettes to pouches.
Coverage from The New York Times, Tobacco Reporter, and Talking Retail emphasizes the commercial success and consumer adoption of these products. Barron's reports that Philip Morris' smoke-free products are gaining favor with both regulators and investors. Future attention may focus on the regulatory environment.
Oncodaily highlights perspectives regarding the FDA's role in protecting public health versus the expansion of profit margins for tobacco companies.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Quick answers
How are nicotine pouches performing in the UK?
According to a Haypp report, they are gaining ground as a vape alternative, with women identified as a key growth driver.
What is the consumer sentiment regarding the switch to pouches?
One survey found that 95% of users are happy moving from cigarettes to pouches.
Which company is noted for its success with smoke-free products?
Philip Morris is reported by Barron's to be winning with regulators and investors.
Coverage (8)
- The new smoke-free craze GZERO Media · 12h ago
- Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK 2Firsts · 12h ago
- Survey Finds 95% Happy Moving from Cigarettes to Pouches Tobacco Reporter · 12h ago
- Haypp Report: Women Emerge as a Key Growth Driver in the UK Nicotine Pouch Market 2Firsts · 12h ago
- Nicotine pouches surge in popularity, report shows Talking Retail · 12h ago
- Lisa A. Lacasse։ The FDA’s Job is to Protect Public Health, Not Expand the Profit Margins of Big Tobacco Oncodaily · 12h ago
- Philip Morris’ Smoke-Free Products Are Winning With Regulators. They’ll Win With Investors Too. Barron's · 12h ago
- Tobacco Companies Are Cashing In on Zyn’s Unstoppable Popularity The New York Times · 12h ago
Topics
Related trends
The New Rules of Sunscreen
The U.S. sunscreen market is shifting as the FDA approves its first new active ingredient in decades.
Potato chip recall upgraded to highest FDA risk level over salmonella concerns
The FDA has upgraded a potato chip recall to its highest risk level due to salmonella concerns, affecting popular brands.
Exclusive: FDA allows ZYN to sell pouches on health benefits
The FDA's decision to allow Philip Morris to market ZYN nicotine pouches as safer than cigarettes is sparking debate.
FDA’s top gene therapy regulator is leaving his role
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
FDA staff raise concerns about peptides as advisory panel with proponents of the molecules is announced
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
The FDA is launching a pilot program to accelerate the review process for new pharmaceutical manufacturing facilities, starting with Eli Lilly and Regeneron.